Recombinant Cynomolgus ARL6IP5 Protein, His-tagged

• Cat.No.: ARL6IP5-312C
• Product Overview: Recombinant Cynomolgus ARL6IP5 full length or partial length protein was expressed.

Specification

• Species: Cynomolgus
• Source: Mammalian Cells
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: ARL6IP5 PRA1 family protein 3 [ Macaca fascicularis (crab-eating macaque) ]
• Official Symbol: ARL6IP5
• Synonyms: ARL6IP5; Aip-5; PRAF3; ADP-ribosylation factor-like protein 6-interacting protein 5; ARL-6-interacting protein 5
• Gene ID: 101925344
• mRNA Refseq: NM_001285150
• Protein Refseq: NP_001272079
• UniProt ID: Q4R4R4

Citation

ARL6IP5 reduces cisplatin-resistance by suppressing DNA repair and promoting apoptosis pathways in ovarian carcinoma

Journal: Cell Death & Disease    PubMed ID: 35293383    Data: 2022/3/15

Authors: Ji-Ye Kim, Entaz Bahar, Hyun-Soo Kim

Article Snippet:rARL6IP5 (#ARL6IP5–9863H; Creative BioMart, NY, USA) is a full-length human ARL6IP5 protein, with a length of 1?188 amino acids and was fused with a glutathione S-transferase-tag at N-terminus.. According to the manufacturer’s information sheet, the protein was produced from E.coli transfection and purified by glutathione-sepharose. rARL6IP5 was added to the culture media for experiments.According to the manufacturer’s information sheet, the protein was produced from E.coli transfection and purified by glutathione-sepharose. rARL6IP5 was added to the culture media for experiments.

A Representative photomicrographs showing ARL6IP5 immunoreactivity (original magnification, ×20; scale bar, 100 μm). Kaplan–Meier plots for B PFS and C OS in 79 patients with ovarian HGSC.

Prognostic significance of ARL6IP5 expression and clinicopathological characteristics in ovarian high-grade serous carcinoma patients.

ARL6IP5, XRCC1, and PARP1 expression was analyzed by western blots in 8 OC cell lines, ES-2, OV-90, TOV21sG, CaOV-4, CaOV-3, TOV112D, SKOV3, OVCAR-3, and one normal ovarian cell line, Hs823.Tc.